ALISA VIEJO, CA — April 18, 2023 — ViaLase, Inc., a clinical stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm with the development of a truly noninvasive image-guided femtosecond laser treatment to enhance glaucoma patient care, today announced that it will present new scientific research during the 2023 […] The post ViaLase to Present New Scientific Data at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting appeared first on Vialase .